EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances and Challenges in Vaccination and Therapeutic Strategies Against Japanese Encephalitis Virus

Jae-Yeon Park, Hye-Mi Lee iD

Pathogens · 2025

DOI: 10.3390/pathogens14121204 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, 2025. Verfasst von Jae-Yeon Park und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea. Hauptthemen laut MEDLINE: Encephalitis Virus, Japanese, Encephalitis, Japanese, Japanese Encephalitis Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Japanese encephalitis virus (JEV) remains a major cause of viral encephalitis in Asia, and recent epidemiological shifts driven by the predominance of genotype I and the re-emergence of genotype V have renewed concerns regarding control efforts. Licensed vaccines have a reduced incidence of more than 90% in several endemic regions; however, evidence of reduced cross-neutralization against heterologous genotypes indicates that vaccines derived from genotype III strains may not fully match the evolving antigenic landscape. This review synthesizes current knowledge on vaccine performance, genotype-driven antigenic variation, and implications for future strain alignment. Emerging platforms, including mRNA, DNA, virus-like particles, and structure-guided recombinant antigens, have been evaluated for their potential to enhance cross-genotype breadth, scalability, and thermostability. We also summarize the progress in antiviral discovery targeting viral nonstructural proteins, host pathways, and monoclonal antibody development, along with immunomodulatory and neuroprotective strategies. Translational challenges, such as blood–brain barrier penetration, therapeutic timing, and durability of immunity, have been highlighted as key barriers to clinical application. By integrating molecular, immunological, and epidemiological evidence, this review outlines strategic directions for developing broad-spectrum vaccines and therapeutics capable of addressing the evolving genetic and ecological landscape of JEV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalitis Virus, JapaneseEncephalitis, JapaneseJapanese Encephalitis VaccinesHumansVaccinationAnimalsGenotypeAntigenic VariationAntiviral Agents

Stichwörter der Autor:innen

Japanese encephalitis virusOne Healthcross-genotype neutralizationgenotype diversitypublic healththerapeutic strategiesvaccination

Substanzen

Japanese Encephalitis VaccinesAntiviral Agents

Autor:innen und Institutionen

  • College of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea.

ORCID-Profile: Hye-Mi Lee

Zitieren

APA

Park, J. Y., & Lee, H. M. (2025). Advances and Challenges in Vaccination and Therapeutic Strategies Against Japanese Encephalitis Virus. Pathogens. https://doi.org/10.3390/pathogens14121204

Vancouver

Park JY, Lee HM. Advances and Challenges in Vaccination and Therapeutic Strategies Against Japanese Encephalitis Virus. Pathogens. 2025. doi:10.3390/pathogens14121204

BibTeX
@article{Park2025,
  author = {Park, Jae-Yeon and Lee, Hye-Mi},
  title = {Advances and Challenges in Vaccination and Therapeutic Strategies Against Japanese Encephalitis Virus},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14121204}
}
Kostenlos starten →